• ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT

INVESTORS

[한국경제] 키메릭항원수용체 T세포(CAR-T) 치료제…내년 하반기 첫 국산 제품 나온다

2024/09/25

키메릭항원수용체 T세포(CAR-T) 치료제…내년 하반기 첫 국산 제품 나온다 | 한국경제 (hankyung.com)

Prev큐로셀, 2024 대한민국 일자리 으뜸기업 선정
Next[히트뉴스] “‘차세대 CAR-T 치료제’ 공동개발 파트너 찾으러 바이오 재팬 왔죠”
Copyright 2023. Curocell Inc. All Rights Reserved.
Created by PRESSCAT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.